Momentus Inc. (MNTS)
CIK 1781162 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 22.0M shares as of Aug 10, 2026 (10-Q). Share count fell from 97.9M to 6.6M between Aug 9, 2023 and Nov 10, 2023, a pattern consistent with a reverse split (roughly 1-for-15); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.
Cash runway
Self-funding
generates cash
Full breakdown: cash runway tool · source filing →
Warrants
| Tranche | Warrants | Exercise price | Term | Notes |
|---|---|---|---|---|
| January2026 Warrants | 925,926 | not tagged | — | — |
| April Pre Funded Warrants | 883,334 | not tagged | — | — |
| May Pre Funded Warrants | 768,580 | not tagged | — | — |
| October2025 Warrants | 418,465 | $13.74 | 5y | — |
| December2025 Warrants | 408,576 | $13.74 | 5y | — |
| August2025 Warrants | 272,385 | $19.81 | 5y | — |
| Common Warrant | 158,925 | $25.17 | — | — |
| May2026 Placement Agent Warrants | 147,100 | $9.35 | — | FV $2.4M |
| Pre Funded Warrants | 120,834 | $0.00001 | — | — |
| March2025 Warrant Inducement | 120,049 | $35.7 | — | — |
| September2025 SIV Warrants | 112,045 | $19.81 | — | — |
| June2026 Placement Agent Warrants | 92,592 | $14.85 | — | FV $700,000 |
Tranches exactly as the company dimensioned them in its 10-Q filed Aug 11, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
Warrants outstanding: 1.7M underlying shares, as reported Nov 8, 2023 (10-K).
Reported exercise price: $4.3175 (aggregate figure as tagged; individual tranches vary).
Balance-sheet fair value of warrants: $2.4M as of Sep 30, 2022.
Down-round (price protection) accounting has been tagged in this filer’s XBRL: some instrument carries repricing protection. Which tranche requires reading the exhibits.
Rough fully diluted estimate: 23.7M = 22.0M O/S + 1.7M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
| Note | Principal | Carrying | Conv. price | Rate | If converted |
|---|---|---|---|---|---|
| SIV Convertible Promissory Notes | $2.7M | — | $14.1 | 15% | ~191,489 sh |
| September 2025 Convertible Note | $1.6M | $700,000 | $19.92 | 8% | ~80,321 sh |
| May Loan Agreement | $1.5M | — | $20.17 | — | ~74,368 sh |
| AGP Convertible Promissory Notes | $500,000 | — | $29.81 | 4.5% | ~16,773 sh |
| January 2026 Convertible Note | not tagged | — | $10 | — | — |
If every note above converted at its tagged price: ~362,951 new shares on 22.0M currently outstanding. An estimate from principal ÷ conversion price, with inputs carrying different as-of dates; make-whole adjustments, capped calls and partial repurchases are not modeled.
Notes exactly as the company dimensioned them in its 10-Q filed Aug 11, 2026 →. Principal is face amount as tagged, not what remains after repurchases unless the filer updated the tag. A note the filer did not dimension is absent here, not absent from the balance sheet; the exhibits stay the ground truth.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 22.0M | Aug 10, 2026 |
| + January2026 Warrants (if exercised) | 925,926 | May 31, 2026 |
| + April Pre Funded Warrants (if exercised) | 883,334 | Apr 14, 2026 |
| + May Pre Funded Warrants (if exercised) | 768,580 | May 26, 2026 |
| + October2025 Warrants (if exercised) | 418,465 | Dec 31, 2025 |
| + December2025 Warrants (if exercised) | 408,576 | Dec 31, 2025 |
| + August2025 Warrants (if exercised) | 272,385 | Aug 13, 2025 |
| + Common Warrant (if exercised) | 158,925 | Jul 1, 2025 |
| + May2026 Placement Agent Warrants (if exercised) | 147,100 | Jun 30, 2026 |
| + Pre Funded Warrants (if exercised) | 120,834 | Jul 1, 2025 |
| + March2025 Warrant Inducement (if exercised) | 120,049 | Mar 20, 2025 |
| + September2025 SIV Warrants (if exercised) | 112,045 | Jun 30, 2026 |
| + June2026 Placement Agent Warrants (if exercised) | 92,592 | Jun 30, 2026 |
| + SIV Convertible Promissory Notes (if fully converted) | 191,489 | Sep 8, 2025 |
| + September 2025 Convertible Note (if fully converted) | 80,321 | Sep 25, 2025 |
| + May Loan Agreement (if fully converted) | 74,368 | May 30, 2025 |
| + AGP Convertible Promissory Notes (if fully converted) | 16,773 | Jun 17, 2025 |
| Fully diluted estimate | 26.8M | +21.8% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Registered offering capacity on live registrations: $224.5Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted
Last 12 months: 17 executed · 10 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full MNTS workspace